Intravenous bufadienolides-loaded lipid microspheres for improving chemical stability

European Journal of Lipid Science and Technology

Volumn 112, Issue 11, 2010, Pages 1190-1199

  Weng, Yan ^a   Li, Fang ^a   Chen, Wei ^a   Miao, Yuqiang ^a   Tang, Xing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Aqueous solution; Bufadienolides; Chemical stability; Degradation kinetics; Lipid microsphere

Indexed keywords

EID: 78349293413     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201000387     Document Type: Article

References (29)

1. Chen, Y., Xiang, J., Gu, W., Xu, M., Chemical constituents of Bufo siccus. Chin. J. Chin. Mater. Med. 1998, 23, 620-621. 640.
2. Chen, K. K., Kovarikove, A., Pharmacology and toxicology of toad venom. J. Pharm. Sci. 1967, 56, 1535- 1541.
3. Li, F., Yang, R., Weng, Y., Tang, X., Preparation and evaluation of lyophilized liposome- encapsulated bufadienolides. Drug Dev. Ind. Pharm. 2009, 35, 1048- 1058.
4. Hashimoto, S., Jing, Y., Kawazoe, N., Masuda, Y., et al. Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leuk. Res. 1997, 21, 875- 883.
5. Kamano, Y., Yamashita, A., Nogawa, T., Morita, H., et al. QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1). J. Med. Chem. 2002, 45, 5440- 5447.
6. Numazawa, S., Shinoki, M. A., Ito, H., Yoshida, T., Kuroiwa, Y., Involvement of Na+, K(+)-ATPase inhibition in K562 cell differentiation induced by bufalin. J. Cell Physiol. 1994, 160, 113- 120.
7. Venkateswarlu, V., Patlolla, R. R., Lipid microspheres as drug delivery systems. Ind. J. Pharm. Sci. 2001, 63, 450- 458.
8. Jumma, M., Müller, B. W., The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int. J. Pharm. 1998, 163, 81- 89.
9. Müller, R. H., Schmidt, S., Buttle, I., Akkar, A., Schmitt, J., et al. SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs. Int. J. Pharm. 2004, 269, 293- 302.
10. Wang, Y. J., Wang, J., Zhang, H. Y., He, H. B., Tang, X., Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres. J. Pharm. Pharmacol. 2007, 59, 351- 357.
11. Ishii, F., Sasaki, I., Ogata, H., Effect of phospholipid emulsifiers on physicochemical properties of intravenous fat emulsions and/or drug carrier emulsions. J. Pharm. Pharmacol. 1990, 42, 513- 515.
12. Davis, S. S., Pharmaceutical aspects of i.v. fat emulsions. J. Hosp. Pharm. 1974, 32, 149- 170.
13. Weingarten, C., Magalhaes, N. S. S., Baszkin, A., Benoita, S., Seiller, M., Interaction of non-ionic ABA copolymer surfactant with phospholipid monolayers: possible relevance to emulsion stabilization. Int. J. Pharm. 1991, 75, 171- 179.
14. Lu, Y., Wang, Y. J., Tang, X., Formulation and thermal sterile stability of a less painful intravenous clarithromycin emulsion containing vitamin E. Int. J. Pharm. 2008, 346, 47- 56.
15. Chen, G., Tao, D., An experimental study of stability of oil-water emulsion. Fuel Process Technol. 2005, 86, 499- 508.
16. Joseph, T. R., The influence of charged lipids on the flocculation and coalescence of oil-in-water emulsions. I. Kinetic assessment of emulsion stability. J. Parent Sci. Technol. 1990, 44, 210- 215.
17. Jukes, T. H., Schmidt, C. L. A., The combination of certain fatty acids with lysine, arginine, and salmine [J]. J. Biol. Chem. 1935, 110, 9- 17.
18. Kamano, Y., Kamatsu, M., Photochemistry of Bufadienolides. I. Irradiation of Bufalin, Bufotalin and Gamabufotalin. Chem. Pharm. Bull. 1969a, 17, 1698- 1705.
19. Kamano, Y., Kamatsu, M., Photochemistry of bufadienolides. II. Irradiation of resibufogenin and 14α-artebufogenin. Chem. Pharm. Bull. 1969b, 17, 1706- 1710.
20. Linde, H., Meyer, K., Zur Konstitution des Resibufogenins und Artebufogenins. Experientia 1958, 14, 238- 240.
21. Herman, C. J., Groves, M. J., Hydrolysis kinetics of phospholipids in thermally stressed intravenous lipid emulsion formulations. J. Pharm. Pharmacol. 1992, 44, 539- 542.
22. Ickenstein, L. M., Sandström, M. C., Mayer, L. D., Edwards, K., Effects of phospholipid hydrolysis on the aggregate structure in DPPC/DSPE-PEG2000 liposome preparations after gel to liquid crystalline phase transition. Biochim. Biophys. Acta. 2006, 1758, 171- 180.
23. Tian, L. L., He, H. B., Tang, X., Stability and degradation kinetics of etoposide-loaded parenteral lipid emulsion. J. Pharm. Sci. 2007, 96, 1719- 1728.
24. Wang, J., Cui, Y., Tang, X., Chemical stability of teniposide in aqueous and parenteral lipid emulsions. Drug Dev. Ind. Pharm. 2009, 35, 508- 513.
25. Krickau, D. P., Mueller, R. H., Thomsen, J., Degradation kinetic of hydrolytically susceptible drugs in O/W emulsions-effects of interfacial area and lecithin. Int. J. Pharm. 2007, 342, 62- 71.
26. Bjerregaard, S., Söderberg, I., Vermehrena, C., Frokjaer, S., Formulation and evaluation of release and swelling mechanism of a water-in-oil emulsion using factorial design. Int. J. Pharm. 1999, 193, 1- 11.
27. Santos Magalhaes, N. S., Cave, G., Seiller, M., Benita, S., The stability and in vitro release kinetics of a clofibride emulsion. Int. J. Pharm. 1991, 76, 225- 237.
28. Jafari, S. M., He, Y., Bhandari, B., Production of sub-micron emulsions by ultrasound and micro fluidization techniques. J. Food Eng. 2007, 82, 478- 488.
29. Constantinides, P. P., Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 1995, 12, 1561- 1572.